0,9945
22-ноября-24 16:44:58
15 мин. задержка
Акции
+0,0045
+0,45%
Сегодняшний диапазон
0,9602 - 1,0200
ISIN
N/A
Источник
NASDAQ
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
17 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference
19 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire